CD8A and lung carcinoma: This is supported by findings that show a correlation between increased global hypomethylation and higher rates of mutation, copy number variations, and allelic imbalances, as well as shifts in the Treg/CD8 ratio during lung cancer progression (as summarized in Table 1).